Oral Biotherapeutics

Injection-free Large Molecule Delivery

Rani Therapeutics has developed a novel approach for the oral delivery of large drug molecules including peptides, proteins and antibodies. We are currently in pre-clinical studies and have demonstrated greater than 50% bioavailability. View a snapshot of our results with Adalimumab and human insulin.

We are currently exploring partnerships with pharmaceutical companies. Contact us to learn more about our innovation and approach.

From our CEO

One advantage of the Rani technology, because we have such a unique formulation approach and unique delivery platform, is that we have taken off-patent drugs and put them back to a 20+ year patent life in combination with our platform

Mir Imran, Chairman & CEO